Study Objective: Better define the pro-inflammatory microenvironment inside ECD lesions. To evaluate the possibility to interfere with the progression of ECD by means of specific inhibitors already available for human usage, in order to find new therapeutic options for the disease.
Principal Investigator: Lorenzo Dagna, M.D., San Raffaele Scientific Institute, Milano, ITALY
Contact Information: Phone: +39-02-26434683 email: [email protected]
Requested Patient Involvement: None known at this time.
